| scholarly article | Q13442814 |
| P50 | author | Gaurav Sahay | Q56997425 |
| Christopher A Alabi | Q88641167 | ||
| P2093 | author name string | Daniel G Anderson | |
| Robert S Langer | |||
| Minglin Ma | |||
| Christopher Zurenko | |||
| George Z Li | |||
| Kathryn A Whitehead | |||
| Kevin T Love | |||
| William Querbes | |||
| P2860 | cites work | ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity | Q24318462 |
| T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice | Q24603574 | ||
| Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates | Q24646644 | ||
| Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Q27860867 | ||
| Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells | Q27860926 | ||
| Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles | Q29615957 | ||
| A combinatorial library of lipid-like materials for delivery of RNAi therapeutics | Q33330928 | ||
| Lipid-like materials for low-dose, in vivo gene silencing | Q33583399 | ||
| Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. | Q33913718 | ||
| Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study | Q34022606 | ||
| Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs | Q34436572 | ||
| Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells | Q34490603 | ||
| Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo | Q34522857 | ||
| Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis | Q34942127 | ||
| Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines | Q35124399 | ||
| Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes | Q35928850 | ||
| Cationic lipids and polymers mediated vectors for delivery of siRNA. | Q36918378 | ||
| Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. | Q37013962 | ||
| Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA | Q37219628 | ||
| Knocking down barriers: advances in siRNA delivery | Q37380671 | ||
| Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA. | Q40028012 | ||
| Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids | Q40391286 | ||
| Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA. | Q41580130 | ||
| Measuring the pH environment of DNA delivered using nonviral vectors: implications for lysosomal trafficking | Q42812764 | ||
| Rational design of cationic lipids for siRNA delivery | Q43191471 | ||
| Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone | Q46674198 | ||
| Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. | Q51794680 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 1688-1694 | |
| P577 | publication date | 2011-07-12 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery | |
| P478 | volume | 19 |
| Q57214413 | A novel Lipidoid-MicroRNA formulation promotes calvarial bone regeneration |
| Q35295342 | A plug-and-play ratiometric pH-sensing nanoprobe for high-throughput investigation of endosomal escape |
| Q46010754 | A window onto siRNA delivery. |
| Q46543595 | Acidic pH-responsive siRNA conjugate for reversible carrier stability and accelerated endosomal escape with reduced IFNα-associated immune response. |
| Q41813002 | Cationic α-cyclodextrin:poly(ethylene glycol) polyrotaxanes for siRNA delivery |
| Q35853451 | Combinatorial Approach to Nanoarchitectonics for Nonviral Delivery of Nucleic Acids |
| Q34093400 | Combinatorial library of lipidoids for in vitro DNA delivery. |
| Q35568750 | Combinatorial library strategies for synthesis of cationic lipid-like nanoparticles and their potential medical applications. |
| Q38692510 | Delivery of therapeutic siRNA to the lung endothelium via novel Lipoplex formulation DACC. |
| Q37111734 | Design of siRNA Therapeutics from the Molecular Scale |
| Q37094403 | ENDOCYTOSIS PATHWAYS FOR NUCLEIC ACID THERAPEUTICS. |
| Q37577606 | Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma |
| Q36195057 | In vitro-in vivo translation of lipid nanoparticles for hepatocellular siRNA delivery |
| Q39003380 | Insight into mechanisms of cellular uptake of lipid nanoparticles and intracellular release of small RNAs. |
| Q28828356 | Lipid-based vectors for siRNA delivery |
| Q37503581 | Lipid-modified aminoglycoside derivatives for in vivo siRNA delivery. |
| Q37424654 | Liposome-like Nanostructures for Drug Delivery |
| Q42031723 | Multi-armed cationic cyclodextrin:poly(ethylene glycol) polyrotaxanes as efficient gene silencing vectors |
| Q34991955 | Rational design of a biomimetic cell penetrating peptide library |
| Q37636279 | Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis |
| Q38021996 | Therapeutic siRNA: principles, challenges, and strategies. |
| Q57139324 | Transfection by cationic gemini lipids and surfactants |
Search more.